Ultragenyx Pharmaceutical Inc. logo

Ultragenyx Pharmaceutical Inc. (RARE)

Market Closed
20 Jul, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
28. 53
-0.75
-2.5615%
$
2.81B Market Cap
- P/E Ratio
- Div Yield
1.19M Volume
-8.23 Eps
$ 29.28
Previous Close
Add Transaction
Day Range
28.5 30.03
Year Range
18.29 39.89
Want to track RARE and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Ultragenyx Pharmaceutical Inc. Investors

Name Quantity Cost Value Profit ($) Gain (%)
SummitTX Capital LP
SummitTX Capital LP SummitTX Capital LP
347,760 $7.29M $10.18M $2.9M 39.76%
BCG
BIT Capital GmbH BIT Capital GmbH
18,000 $377,100 $527,040 $149,940 39.76%
Scott Schroeder
Scott Schroeder Longaeva Partners LP
228,107 $4.78M $6.68M $1.9M 39.76%
BM
Berkeley Meredith Hughes Financial Services LLC
1 $21 $29.28 $8.28 39.43%
Yuen Man Lee
Yuen Man Lee Persistent Asset Partners Ltd.
8,884 $204,332 $260,123.52 $55,791.52 27.3%
RFL
Rossby Financial LLC Rossby Financial LLC
39 $835 $1,141.92 $306.92 36.76%
GFM
GF Fund Management Co. Ltd. GF Fund Management Co. Ltd.
2,166 $82,909.76 $63,420.48 -$19,489.28 -23.51%
JCB
John Ciaran Burns Universal-Beteiligungs- und Servicegesellschaft mbH
15,478 $588,001.18 $453,195.84 -$134,805.34 -22.93%
Nicole Reese
Nicole Reese WPG Advisers LLC
11 $462.75 $322.08 -$140.67 -30.4%
Boreal Capital Management LLC
Boreal Capital Management LLC Boreal Capital Management LLC
100 $3,636 $2,928 -$708 -19.47%